Creative Medical Technology Holdings, Inc. - Common Stock (CELZ)
2.1400
+0.1400 (7.00%)
NASDAQ · Last Trade: Apr 3rd, 3:57 AM EDT
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · March 28, 2025

Via Benzinga · February 14, 2025

Via Benzinga · October 23, 2024

It seems time for the Securities and Exchange Commission to oversee stock advertising and consider a ban, or at least a danger warning label.
Via Talk Markets · October 9, 2024

CELZ stock results show that Creative Medical Tech missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 12, 2024

CELZ stock results show that Creative Medical Tech beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 13, 2024

Via Benzinga · March 7, 2024

FDA approval under expanded access for Creative Medical. CELZ-201, a pioneering cell-based program, targets abnormal glucose tolerance to prevent Type 1 diabetes.
Via Benzinga · March 7, 2024

Via Benzinga · March 7, 2024

Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Via Benzinga · March 7, 2024

Via Benzinga · March 6, 2024

Via Benzinga · March 6, 2024

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company has received clearance from the FDA to conduct a phase 1/2 clinical trial using their innovative StemSpine® treatment known as AlloStem™.
Via Benzinga · December 19, 2023

Via Benzinga · October 31, 2023

It's time for another busy day of trading as we go over the biggest pre-market stock movers worth watching on Tuesday morning!
Via InvestorPlace · October 31, 2023

It's time to start off the week with a breakdown of the biggest pre-market stock movers that investors need to know about for Monday!
Via InvestorPlace · October 9, 2023

Via Benzinga · September 13, 2023

Via Benzinga · September 13, 2023

Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares rose 38.7% to $0.1713 in pre-market trading. Shares of Avalo Therapeutics jumped over 45% on Tuesday after the company agreed to divest AVTX-800 series.
Via Benzinga · September 13, 2023

It's time for another dive into the biggest pre-market stock movers as we check out all the shares worth watching on Wednesday!
Via InvestorPlace · September 13, 2023

Biotechnology company Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) seems to be witnessing success in the allogeneic cell therapy market.
Via Benzinga · August 23, 2023

Gainers
Via Benzinga · August 3, 2023

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares surged 52.1% to $0.1049 in pre-market trading.
Via Benzinga · August 2, 2023

It's time for another breakdown of the biggest pre-market stock movers as we check out all of the latest news for Wednesday!
Via InvestorPlace · August 2, 2023

Via Benzinga · August 1, 2023